Medical | Eileen Yoshida, BScPhm, MBA| March 06, 2019
Explore new approaches to combating opioid misuse with DynaMed Deputy Editor of Medication and Clinical Informatics, Eileen Yoshida, BScPhm, MBA.
Every day, more than 130 people in the United States die after overdosing on opioids.1 The misuse of and addiction to opioids is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.2
Canada is also experiencing a serious opioid crisis. More than 9,000 people lost their lives in Canada between January 2016 and June 2018 related to opioids. The opioid epidemic has affected every part of the country; however, certain regions have been impacted more than others. Based on available data, there were 2,066 apparent opioid-related deaths in Canada between January and June 2018; 94% were accidental.3
During the recent HIMSS meeting in Orlando, FL, several leading organizations shared their institutions’ efforts to combat the opioid epidemic. While the specific tactics employed varied among institutions, common themes were also employed, including the establishment of a clear governance structure, clinician education, incorporation of best practice into the clinician workflow and pre-established outcome measurements.
Every day, more than 130 people in the United States die after overdosing on opioids.
One U.S.-based site provided a summary of ongoing initiatives to decrease overall opioid prescribing and increase more appropriate prescribing within their organization.4
The health system demonstrated a decrease in the overall number of opioid prescriptions dispensed, decrease in the average MEDD/Rx and an increase in adherence to guidelines across multiple settings of care.
A Canadian-based site reported on their efforts to improve the appropriate prescribing of buprenorphine/naloxone to patients presenting to their emergency room for opioid withdrawal, via the development of an interdisciplinary pathway and order set.5 Post intervention, the health system demonstrated increased rates of initiation of buprenorphine/naloxone therapy, a decrease in repeat visits to the emergency room for opioid withdrawal patients, and a decreased average wait times between emergency room visit and coordination of care for after visit services.
To get the most current information on opioid withdrawal, view the free topic from DynaMed Plus by clicking the link below.
Eileen Yoshida is the Deputy Editor of Medication and Clinical Informatics at DynaMed. In this role, she leads the medication and clinical informatics strategies for the organization. Eileen brings over 25 years of experience in the healthcare industry, most recently leading the Clinical Knowledge Management and Decision Support team at Partners HealthCare. Previously, she served with Capgemini as an EHR implementation strategist and with the University of Chicago Hospitals in a special projects role. Eileen has extensive experience in clinical informatics, EHR implementation, healthcare consulting and clinical pharmacy and is a published author and speaker on clinical decision support. She holds a degree in Pharmacy from the University of Toronto and a Masters in Business Administration from the Kellogg School of Management at Northwestern University.
Your comment will be reviewed by a moderator for approval.